25I-NB4OMe

25I-NB4OMe
Clinical data
ATC code	none;
Legal status
Legal status	UK: Class A drug;
Identifiers
	IUPAC name 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(4-methoxyphenyl)methyl]ethanamine;
CAS Number	1566571-41-2 ;
PubChem CID	118796481;
ChemSpider	52085624 ;
UNII	IVG065DV7J;
Chemical and physical data
Formula	C18H22INO3
Molar mass	427.282 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC1=CC=C(C=C1)CNCCC2=CC(=C(C=C2OC)I)OC;
	InChI InChI=1S/C18H22INO3.ClH/c1-21-15-6-4-13(5-7-15)12-20-9-8-14-10-18(23-3)16(19)11-17(14)22-2;/h4-7,10-11,20H,8-9,12H2,1-3H3;1H; Key:NWOROGLTELSWAZ-UHFFFAOYSA-N;

25I-NB4OMe (2C-I-NB4OMe, NB4OMe-2C-I) is a derivative of the phenethylamine hallucinogen 2C-I, which acts as a partial agonist for the human 5-HT_2A receptor.^[1]

Legality

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.^[2]

^ Hansen M, Phonekeo K, Paine JS, Leth-Petersen S, Begtrup M, Bräuner-Osborne H, Kristensen JL (March 2014). "Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT_2A/2C agonists". ACS Chemical Neuroscience. 5 (3): 243–249. doi:10.1021/cn400216u. PMC 3963123. PMID 24397362.
^ "The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014". UK Statutory Instruments 2014 No. 1106. www.legislation.gov.uk.

Clinical data

ATC code	none
Legal status
Legal status	UK: Class A drug
Identifiers
IUPAC name 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(4-methoxyphenyl)methyl]ethanamine
CAS Number	1566571-41-2^Y
PubChem CID	118796481
ChemSpider	52085624^Y
UNII	IVG065DV7J
Chemical and physical data
Formula	C₁₈H₂₂INO₃
Molar mass	427.282 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES COC1=CC=C(C=C1)CNCCC2=CC(=C(C=C2OC)I)OC
InChI InChI=1S/C18H22INO3.ClH/c1-21-15-6-4-13(5-7-15)12-20-9-8-14-10-18(23-3)16(19)11-17(14)22-2;/h4-7,10-11,20H,8-9,12H2,1-3H3;1H Key:NWOROGLTELSWAZ-UHFFFAOYSA-N